Three items decreased from the previous year, with the largest decreases for Levothyroxine sodium (1.7%) and Omeprazole (0.4%).
Cafwyd y gostyngiadau mwyaf ar gyfer Levothyroxine sodium (1.7%) ac Omeprazole (0.4%).